29 lugl 2020 anni - The FDA grants Truvian the first EUA for a rapid antibody test. The company reported a sensitivity rate of 98.44% (very low % of false negatives) and a specificity rate of 98.9% (very low % of false positive).
Aggiunto al nastro di tempo:
Data:
29 lugl 2020 anni
Adesso
~ 3 years and 9 months ago
